CAMELLE REDDING: Open Payments
NPI 1326335829 · OWINGS MILLS, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,397 in 61 payments from 17 companies in 2025. Trend: 2023 $1,039 · 2024 $2,101 · 2025 $1,397
Food & beverage: $1,397
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $314 |
| Novo Nordisk Inc | 9 | $216 |
| PFIZER INC. | 10 | $168 |
| Lilly USA, LLC | 7 | $133 |
| Exact Sciences Corporation | 3 | $73 |
| GlaxoSmithKline, LLC. | 4 | $71 |
| Kowa Pharmaceuticals America, Inc. | 4 | $67 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $53 |
| ABBVIE INC. | 2 | $49 |
| Sumitomo Pharma America, Inc. | 2 | $45 |
Products named: AIRSUPRA, FARXIGA, Rybelsus, Ozempic, MOUNJARO, JARDIANCE, NURTEC ODT, VYNDAQEL.
Industry payments across MD — which companies pay providers there.
